Global Vitamin K Antagonists (VKA) Market Growth 2022-2028
![](/report_cover/10189/global-vitamin-k-antagonists-vka-market-growth-2018-2023_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Vitamin K Antagonists (VKA) will have significant change from previous year. According to our (LP Information) latest study, the global Vitamin K Antagonists (VKA) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vitamin K Antagonists (VKA) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Vitamin K Antagonists (VKA) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vitamin K Antagonists (VKA) market, reaching US$ million by the year 2028. As for the Europe Vitamin K Antagonists (VKA) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vitamin K Antagonists (VKA) players cover Sanofi, Bristol-Myers Squibb, Bayer, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin K Antagonists (VKA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Vitamin K Antagonists (VKA) will have significant change from previous year. According to our (LP Information) latest study, the global Vitamin K Antagonists (VKA) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vitamin K Antagonists (VKA) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Vitamin K Antagonists (VKA) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vitamin K Antagonists (VKA) market, reaching US$ million by the year 2028. As for the Europe Vitamin K Antagonists (VKA) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vitamin K Antagonists (VKA) players cover Sanofi, Bristol-Myers Squibb, Bayer, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin K Antagonists (VKA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Oral Vitamin K Antagonists
- Injection Vitamin K Antagonists
- VTE
- ACS/MI
- AF
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Johnson & Johnson
- Genentech (Roche)
- Boehringer Ingelheim
- Lilly
- Daiichi Sankyo
- Otsuka
- AstraZeneca
- Pfizer
- Aspen
- The Medicines Company
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vitamin K Antagonists (VKA) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Country/Region, 2017, 2022 & 2028
2.2 Vitamin K Antagonists (VKA) Segment by Type
2.2.1 Oral Vitamin K Antagonists
2.2.2 Injection Vitamin K Antagonists
2.3 Vitamin K Antagonists (VKA) Sales by Type
2.3.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
2.3.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022)
2.4 Vitamin K Antagonists (VKA) Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Vitamin K Antagonists (VKA) Sales by Application
2.5.1 Global Vitamin K Antagonists (VKA) Sale Market Share by Application (2017-2022)
2.5.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022)
3 GLOBAL VITAMIN K ANTAGONISTS (VKA) BY COMPANY
3.1 Global Vitamin K Antagonists (VKA) Breakdown Data by Company
3.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Company (2020-2022)
3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)
3.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Company (2020-2022)
3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022)
3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)
3.3 Global Vitamin K Antagonists (VKA) Sale Price by Company
3.4 Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vitamin K Antagonists (VKA) Product Location Distribution
3.4.2 Players Vitamin K Antagonists (VKA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VITAMIN K ANTAGONISTS (VKA) BY GEOGRAPHIC REGION
4.1 World Historic Vitamin K Antagonists (VKA) Market Size by Geographic Region (2017-2022)
4.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Geographic Region
4.2 World Historic Vitamin K Antagonists (VKA) Market Size by Country/Region (2017-2022)
4.2.1 Global Vitamin K Antagonists (VKA) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Country/Region
4.3 Americas Vitamin K Antagonists (VKA) Sales Growth
4.4 APAC Vitamin K Antagonists (VKA) Sales Growth
4.5 Europe Vitamin K Antagonists (VKA) Sales Growth
4.6 Middle East & Africa Vitamin K Antagonists (VKA) Sales Growth
5 AMERICAS
5.1 Americas Vitamin K Antagonists (VKA) Sales by Country
5.1.1 Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
5.1.2 Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
5.2 Americas Vitamin K Antagonists (VKA) Sales by Type
5.3 Americas Vitamin K Antagonists (VKA) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vitamin K Antagonists (VKA) Sales by Region
6.1.1 APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022)
6.1.2 APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022)
6.2 APAC Vitamin K Antagonists (VKA) Sales by Type
6.3 APAC Vitamin K Antagonists (VKA) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vitamin K Antagonists (VKA) by Country
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
7.2 Europe Vitamin K Antagonists (VKA) Sales by Type
7.3 Europe Vitamin K Antagonists (VKA) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vitamin K Antagonists (VKA) by Country
8.1.1 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
8.2 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type
8.3 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA)
10.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
10.4 Industry Chain Structure of Vitamin K Antagonists (VKA)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vitamin K Antagonists (VKA) Distributors
11.3 Vitamin K Antagonists (VKA) Customer
12 WORLD FORECAST REVIEW FOR VITAMIN K ANTAGONISTS (VKA) BY GEOGRAPHIC REGION
12.1 Global Vitamin K Antagonists (VKA) Market Size Forecast by Region
12.1.1 Global Vitamin K Antagonists (VKA) Forecast by Region (2023-2028)
12.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vitamin K Antagonists (VKA) Forecast by Type
12.7 Global Vitamin K Antagonists (VKA) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Vitamin K Antagonists (VKA) Product Offered
13.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered
13.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Vitamin K Antagonists (VKA) Product Offered
13.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered
13.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Genentech (Roche)
13.5.1 Genentech (Roche) Company Information
13.5.2 Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered
13.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Genentech (Roche) Main Business Overview
13.5.5 Genentech (Roche) Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered
13.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Lilly
13.7.1 Lilly Company Information
13.7.2 Lilly Vitamin K Antagonists (VKA) Product Offered
13.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lilly Main Business Overview
13.7.5 Lilly Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered
13.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 Otsuka
13.9.1 Otsuka Company Information
13.9.2 Otsuka Vitamin K Antagonists (VKA) Product Offered
13.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Otsuka Main Business Overview
13.9.5 Otsuka Latest Developments
13.10 AstraZeneca
13.10.1 AstraZeneca Company Information
13.10.2 AstraZeneca Vitamin K Antagonists (VKA) Product Offered
13.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 AstraZeneca Main Business Overview
13.10.5 AstraZeneca Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Vitamin K Antagonists (VKA) Product Offered
13.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Aspen
13.12.1 Aspen Company Information
13.12.2 Aspen Vitamin K Antagonists (VKA) Product Offered
13.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aspen Main Business Overview
13.12.5 Aspen Latest Developments
13.13 The Medicines Company
13.13.1 The Medicines Company Company Information
13.13.2 The Medicines Company Vitamin K Antagonists (VKA) Product Offered
13.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 The Medicines Company Main Business Overview
13.13.5 The Medicines Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vitamin K Antagonists (VKA) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Country/Region, 2017, 2022 & 2028
2.2 Vitamin K Antagonists (VKA) Segment by Type
2.2.1 Oral Vitamin K Antagonists
2.2.2 Injection Vitamin K Antagonists
2.3 Vitamin K Antagonists (VKA) Sales by Type
2.3.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
2.3.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022)
2.4 Vitamin K Antagonists (VKA) Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Vitamin K Antagonists (VKA) Sales by Application
2.5.1 Global Vitamin K Antagonists (VKA) Sale Market Share by Application (2017-2022)
2.5.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022)
3 GLOBAL VITAMIN K ANTAGONISTS (VKA) BY COMPANY
3.1 Global Vitamin K Antagonists (VKA) Breakdown Data by Company
3.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Company (2020-2022)
3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)
3.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Company (2020-2022)
3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022)
3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)
3.3 Global Vitamin K Antagonists (VKA) Sale Price by Company
3.4 Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vitamin K Antagonists (VKA) Product Location Distribution
3.4.2 Players Vitamin K Antagonists (VKA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VITAMIN K ANTAGONISTS (VKA) BY GEOGRAPHIC REGION
4.1 World Historic Vitamin K Antagonists (VKA) Market Size by Geographic Region (2017-2022)
4.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Geographic Region
4.2 World Historic Vitamin K Antagonists (VKA) Market Size by Country/Region (2017-2022)
4.2.1 Global Vitamin K Antagonists (VKA) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Country/Region
4.3 Americas Vitamin K Antagonists (VKA) Sales Growth
4.4 APAC Vitamin K Antagonists (VKA) Sales Growth
4.5 Europe Vitamin K Antagonists (VKA) Sales Growth
4.6 Middle East & Africa Vitamin K Antagonists (VKA) Sales Growth
5 AMERICAS
5.1 Americas Vitamin K Antagonists (VKA) Sales by Country
5.1.1 Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
5.1.2 Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
5.2 Americas Vitamin K Antagonists (VKA) Sales by Type
5.3 Americas Vitamin K Antagonists (VKA) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vitamin K Antagonists (VKA) Sales by Region
6.1.1 APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022)
6.1.2 APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022)
6.2 APAC Vitamin K Antagonists (VKA) Sales by Type
6.3 APAC Vitamin K Antagonists (VKA) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vitamin K Antagonists (VKA) by Country
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
7.2 Europe Vitamin K Antagonists (VKA) Sales by Type
7.3 Europe Vitamin K Antagonists (VKA) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vitamin K Antagonists (VKA) by Country
8.1.1 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)
8.2 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type
8.3 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA)
10.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
10.4 Industry Chain Structure of Vitamin K Antagonists (VKA)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vitamin K Antagonists (VKA) Distributors
11.3 Vitamin K Antagonists (VKA) Customer
12 WORLD FORECAST REVIEW FOR VITAMIN K ANTAGONISTS (VKA) BY GEOGRAPHIC REGION
12.1 Global Vitamin K Antagonists (VKA) Market Size Forecast by Region
12.1.1 Global Vitamin K Antagonists (VKA) Forecast by Region (2023-2028)
12.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vitamin K Antagonists (VKA) Forecast by Type
12.7 Global Vitamin K Antagonists (VKA) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Vitamin K Antagonists (VKA) Product Offered
13.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered
13.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Vitamin K Antagonists (VKA) Product Offered
13.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered
13.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Genentech (Roche)
13.5.1 Genentech (Roche) Company Information
13.5.2 Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered
13.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Genentech (Roche) Main Business Overview
13.5.5 Genentech (Roche) Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered
13.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Lilly
13.7.1 Lilly Company Information
13.7.2 Lilly Vitamin K Antagonists (VKA) Product Offered
13.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lilly Main Business Overview
13.7.5 Lilly Latest Developments
13.8 Daiichi Sankyo
13.8.1 Daiichi Sankyo Company Information
13.8.2 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered
13.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Daiichi Sankyo Main Business Overview
13.8.5 Daiichi Sankyo Latest Developments
13.9 Otsuka
13.9.1 Otsuka Company Information
13.9.2 Otsuka Vitamin K Antagonists (VKA) Product Offered
13.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Otsuka Main Business Overview
13.9.5 Otsuka Latest Developments
13.10 AstraZeneca
13.10.1 AstraZeneca Company Information
13.10.2 AstraZeneca Vitamin K Antagonists (VKA) Product Offered
13.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 AstraZeneca Main Business Overview
13.10.5 AstraZeneca Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Vitamin K Antagonists (VKA) Product Offered
13.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Aspen
13.12.1 Aspen Company Information
13.12.2 Aspen Vitamin K Antagonists (VKA) Product Offered
13.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aspen Main Business Overview
13.12.5 Aspen Latest Developments
13.13 The Medicines Company
13.13.1 The Medicines Company Company Information
13.13.2 The Medicines Company Vitamin K Antagonists (VKA) Product Offered
13.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 The Medicines Company Main Business Overview
13.13.5 The Medicines Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vitamin K Antagonists (VKA) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vitamin K Antagonists (VKA) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Vitamin K Antagonists
Table 4. Major Players of Injection Vitamin K Antagonists
Table 5. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 6. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 7. Global Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)
Table 9. Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 12. Global Vitamin K Antagonists (VKA) Revenue by Application (2017-2022)
Table 13. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2022)
Table 14. Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Vitamin K Antagonists (VKA) Sales by Company (2020-2022) & (K MT)
Table 16. Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)
Table 17. Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)
Table 19. Global Vitamin K Antagonists (VKA) Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution and Sales Area
Table 21. Players Vitamin K Antagonists (VKA) Products Offered
Table 22. Vitamin K Antagonists (VKA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vitamin K Antagonists (VKA) Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Vitamin K Antagonists (VKA) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vitamin K Antagonists (VKA) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vitamin K Antagonists (VKA) Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Vitamin K Antagonists (VKA) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vitamin K Antagonists (VKA) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 34. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 35. Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 37. Americas Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 38. Americas Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 39. Americas Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 40. Americas Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 41. APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022) & (K MT)
Table 42. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Table 43. APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Region (2017-2022)
Table 45. APAC Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 46. APAC Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 47. APAC Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 48. APAC Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 49. Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 50. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 51. Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 53. Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 54. Europe Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 55. Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 56. Europe Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vitamin K Antagonists (VKA)
Table 66. Key Market Challenges & Risks of Vitamin K Antagonists (VKA)
Table 67. Key Industry Trends of Vitamin K Antagonists (VKA)
Table 68. Vitamin K Antagonists (VKA) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vitamin K Antagonists (VKA) Distributors List
Table 71. Vitamin K Antagonists (VKA) Customer List
Table 72. Global Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Vitamin K Antagonists (VKA) Sales Market Forecast by Region
Table 74. Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Vitamin K Antagonists (VKA) Product Offered
Table 94. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered
Table 99. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Bayer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer Vitamin K Antagonists (VKA) Product Offered
Table 104. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Bayer Main Business
Table 106. Bayer Latest Developments
Table 107. Johnson & Johnson Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered
Table 109. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Genentech (Roche) Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 113. Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered
Table 114. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Genentech (Roche) Main Business
Table 116. Genentech (Roche) Latest Developments
Table 117. Boehringer Ingelheim Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 118. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered
Table 119. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Boehringer Ingelheim Main Business
Table 121. Boehringer Ingelheim Latest Developments
Table 122. Lilly Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 123. Lilly Vitamin K Antagonists (VKA) Product Offered
Table 124. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Lilly Main Business
Table 126. Lilly Latest Developments
Table 127. Daiichi Sankyo Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 128. Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered
Table 129. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Daiichi Sankyo Main Business
Table 131. Daiichi Sankyo Latest Developments
Table 132. Otsuka Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 133. Otsuka Vitamin K Antagonists (VKA) Product Offered
Table 134. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Otsuka Main Business
Table 136. Otsuka Latest Developments
Table 137. AstraZeneca Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 138. AstraZeneca Vitamin K Antagonists (VKA) Product Offered
Table 139. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 140. AstraZeneca Main Business
Table 141. AstraZeneca Latest Developments
Table 142. Pfizer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 143. Pfizer Vitamin K Antagonists (VKA) Product Offered
Table 144. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 145. Pfizer Main Business
Table 146. Pfizer Latest Developments
Table 147. Aspen Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 148. Aspen Vitamin K Antagonists (VKA) Product Offered
Table 149. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 150. Aspen Main Business
Table 151. Aspen Latest Developments
Table 152. The Medicines Company Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 153. The Medicines Company Vitamin K Antagonists (VKA) Product Offered
Table 154. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 155. The Medicines Company Main Business
Table 156. The Medicines Company Latest Developments
Table 1. Vitamin K Antagonists (VKA) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vitamin K Antagonists (VKA) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Vitamin K Antagonists
Table 4. Major Players of Injection Vitamin K Antagonists
Table 5. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 6. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 7. Global Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)
Table 9. Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 12. Global Vitamin K Antagonists (VKA) Revenue by Application (2017-2022)
Table 13. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2022)
Table 14. Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Vitamin K Antagonists (VKA) Sales by Company (2020-2022) & (K MT)
Table 16. Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)
Table 17. Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)
Table 19. Global Vitamin K Antagonists (VKA) Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution and Sales Area
Table 21. Players Vitamin K Antagonists (VKA) Products Offered
Table 22. Vitamin K Antagonists (VKA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vitamin K Antagonists (VKA) Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Vitamin K Antagonists (VKA) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vitamin K Antagonists (VKA) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vitamin K Antagonists (VKA) Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Vitamin K Antagonists (VKA) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vitamin K Antagonists (VKA) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 34. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 35. Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 37. Americas Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 38. Americas Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 39. Americas Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 40. Americas Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 41. APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022) & (K MT)
Table 42. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Table 43. APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Region (2017-2022)
Table 45. APAC Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 46. APAC Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 47. APAC Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 48. APAC Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 49. Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 50. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 51. Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 53. Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 54. Europe Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 55. Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 56. Europe Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vitamin K Antagonists (VKA)
Table 66. Key Market Challenges & Risks of Vitamin K Antagonists (VKA)
Table 67. Key Industry Trends of Vitamin K Antagonists (VKA)
Table 68. Vitamin K Antagonists (VKA) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vitamin K Antagonists (VKA) Distributors List
Table 71. Vitamin K Antagonists (VKA) Customer List
Table 72. Global Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Vitamin K Antagonists (VKA) Sales Market Forecast by Region
Table 74. Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Vitamin K Antagonists (VKA) Product Offered
Table 94. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered
Table 99. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Bayer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer Vitamin K Antagonists (VKA) Product Offered
Table 104. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Bayer Main Business
Table 106. Bayer Latest Developments
Table 107. Johnson & Johnson Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered
Table 109. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Genentech (Roche) Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 113. Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered
Table 114. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Genentech (Roche) Main Business
Table 116. Genentech (Roche) Latest Developments
Table 117. Boehringer Ingelheim Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 118. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered
Table 119. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Boehringer Ingelheim Main Business
Table 121. Boehringer Ingelheim Latest Developments
Table 122. Lilly Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 123. Lilly Vitamin K Antagonists (VKA) Product Offered
Table 124. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Lilly Main Business
Table 126. Lilly Latest Developments
Table 127. Daiichi Sankyo Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 128. Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered
Table 129. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Daiichi Sankyo Main Business
Table 131. Daiichi Sankyo Latest Developments
Table 132. Otsuka Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 133. Otsuka Vitamin K Antagonists (VKA) Product Offered
Table 134. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Otsuka Main Business
Table 136. Otsuka Latest Developments
Table 137. AstraZeneca Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 138. AstraZeneca Vitamin K Antagonists (VKA) Product Offered
Table 139. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 140. AstraZeneca Main Business
Table 141. AstraZeneca Latest Developments
Table 142. Pfizer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 143. Pfizer Vitamin K Antagonists (VKA) Product Offered
Table 144. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 145. Pfizer Main Business
Table 146. Pfizer Latest Developments
Table 147. Aspen Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 148. Aspen Vitamin K Antagonists (VKA) Product Offered
Table 149. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 150. Aspen Main Business
Table 151. Aspen Latest Developments
Table 152. The Medicines Company Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 153. The Medicines Company Vitamin K Antagonists (VKA) Product Offered
Table 154. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 155. The Medicines Company Main Business
Table 156. The Medicines Company Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vitamin K Antagonists (VKA)
Figure 2. Vitamin K Antagonists (VKA) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vitamin K Antagonists (VKA) Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Vitamin K Antagonists (VKA) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vitamin K Antagonists (VKA) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Vitamin K Antagonists
Figure 10. Product Picture of Injection Vitamin K Antagonists
Figure 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2021
Figure 12. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)
Figure 13. Vitamin K Antagonists (VKA) Consumed in VTE
Figure 14. Global Vitamin K Antagonists (VKA) Market: VTE (2017-2022) & (K MT)
Figure 15. Vitamin K Antagonists (VKA) Consumed in ACS/MI
Figure 16. Global Vitamin K Antagonists (VKA) Market: ACS/MI (2017-2022) & (K MT)
Figure 17. Vitamin K Antagonists (VKA) Consumed in AF
Figure 18. Global Vitamin K Antagonists (VKA) Market: AF (2017-2022) & (K MT)
Figure 19. Vitamin K Antagonists (VKA) Consumed in Others
Figure 20. Global Vitamin K Antagonists (VKA) Market: Others (2017-2022) & (K MT)
Figure 21. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Figure 22. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application in 2021
Figure 23. Vitamin K Antagonists (VKA) Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company in 2021
Figure 25. Global Vitamin K Antagonists (VKA) Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region in 2021
Figure 27. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Figure 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region in 2021
Figure 29. Americas Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 30. Americas Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 31. APAC Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 32. APAC Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 33. Europe Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 34. Europe Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 36. Middle East & Africa Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 37. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 38. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 39. United States Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region in 2021
Figure 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Regions in 2021
Figure 45. China Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 53. Germany Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 60. Egypt Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA) in 2021
Figure 66. Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
Figure 67. Industry Chain Structure of Vitamin K Antagonists (VKA)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Vitamin K Antagonists (VKA)
Figure 2. Vitamin K Antagonists (VKA) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vitamin K Antagonists (VKA) Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Vitamin K Antagonists (VKA) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vitamin K Antagonists (VKA) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Vitamin K Antagonists
Figure 10. Product Picture of Injection Vitamin K Antagonists
Figure 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2021
Figure 12. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)
Figure 13. Vitamin K Antagonists (VKA) Consumed in VTE
Figure 14. Global Vitamin K Antagonists (VKA) Market: VTE (2017-2022) & (K MT)
Figure 15. Vitamin K Antagonists (VKA) Consumed in ACS/MI
Figure 16. Global Vitamin K Antagonists (VKA) Market: ACS/MI (2017-2022) & (K MT)
Figure 17. Vitamin K Antagonists (VKA) Consumed in AF
Figure 18. Global Vitamin K Antagonists (VKA) Market: AF (2017-2022) & (K MT)
Figure 19. Vitamin K Antagonists (VKA) Consumed in Others
Figure 20. Global Vitamin K Antagonists (VKA) Market: Others (2017-2022) & (K MT)
Figure 21. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)
Figure 22. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application in 2021
Figure 23. Vitamin K Antagonists (VKA) Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company in 2021
Figure 25. Global Vitamin K Antagonists (VKA) Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region in 2021
Figure 27. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)
Figure 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region in 2021
Figure 29. Americas Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 30. Americas Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 31. APAC Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 32. APAC Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 33. Europe Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 34. Europe Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)
Figure 36. Middle East & Africa Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)
Figure 37. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 38. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 39. United States Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region in 2021
Figure 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Regions in 2021
Figure 45. China Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 53. Germany Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021
Figure 60. Egypt Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA) in 2021
Figure 66. Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
Figure 67. Industry Chain Structure of Vitamin K Antagonists (VKA)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles